Memorial Sloan-Kettering Cancer Center

Our Results

Close Printer Formatted Version
Our Team of Experts
Our Team of Experts
Because of the expertise of our transplant team, our patients often have excellent results

Patients fare best when treated by physicians who have extensive experience overseeing transplantation and managing its potential complications.

Over the past three decades, our physicians have developed particularly effective treatment regimens that include transplantation for specific diseases.

Acute Myelogenous Leukemia

Younger patients -- 20 to 40 years old -- with acute myelogenous leukemia who are treated at Memorial Sloan-Kettering have excellent prospects of disease-free survival (80 percent), while older patients beyond the age of 40 fare almost as well (72 percent) after allogeneic transplant. We even tranaplant patients older than 60 who are otherwise medically fit.

Amyloidosis

Physicians here are known nationally and internationally for the treatment of amyloidosis, Hodgkin's disease, and non-Hodgkin's lymphoma. A close-knit team of physicians and nurses from both our lymphoma and transplant services work together to oversee transplantation in these patients, providing coordination and continuity of care.

Testicular Cancer

Research Milestones
Research Milestones
Three decades of achievements in the advancement of therapy

Testicular cancer is more sensitive to chemotherapy than other solid tumors. A first-line treatment that includes autologous stem cell rescue has been shown to be the most likely cure in testicular cancer patients with poor risk factors. Memorial Sloan-Kettering is recognized as a leader in the treatment of this disease, and patients are referred here from hospitals around the country and abroad.

©2008 Memorial Sloan-Kettering Cancer Center.